ATE320266T1 - Induktion von antigen-spezifischen t-zellen durch interferon - Google Patents

Induktion von antigen-spezifischen t-zellen durch interferon

Info

Publication number
ATE320266T1
ATE320266T1 AT00306263T AT00306263T ATE320266T1 AT E320266 T1 ATE320266 T1 AT E320266T1 AT 00306263 T AT00306263 T AT 00306263T AT 00306263 T AT00306263 T AT 00306263T AT E320266 T1 ATE320266 T1 AT E320266T1
Authority
AT
Austria
Prior art keywords
antigen
induction
cells
specific
interferon
Prior art date
Application number
AT00306263T
Other languages
English (en)
Inventor
Hideo Takasu
Masashi Gotoh
Takashi Yamaoka
Original Assignee
Dainippon Sumitomo Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dainippon Sumitomo Pharma Co filed Critical Dainippon Sumitomo Pharma Co
Application granted granted Critical
Publication of ATE320266T1 publication Critical patent/ATE320266T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55522—Cytokines; Lymphokines; Interferons

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT00306263T 1999-07-22 2000-07-24 Induktion von antigen-spezifischen t-zellen durch interferon ATE320266T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP20768799 1999-07-22

Publications (1)

Publication Number Publication Date
ATE320266T1 true ATE320266T1 (de) 2006-04-15

Family

ID=16543925

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00306263T ATE320266T1 (de) 1999-07-22 2000-07-24 Induktion von antigen-spezifischen t-zellen durch interferon

Country Status (4)

Country Link
EP (2) EP1681064A1 (de)
AT (1) ATE320266T1 (de)
CA (1) CA2313392A1 (de)
DE (1) DE60026666T2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1103564B1 (de) 1998-07-31 2009-01-07 International Institute of Cancer Immunology, Inc. Krebsantigene, basierend auf dem tumorunterdrückenden genprodukt wt1
BRPI0208183B8 (pt) 2001-03-22 2021-05-25 Sugiyama Haruo peptídeo antígeno de câncer modificado por wt1 e vacinas para câncer
EP1250933A1 (de) * 2001-04-17 2002-10-23 Istituto Superiore di Sanità Impfstoffe mit hochdosiertem Typ I IFN als Adjuvans
CA2471735A1 (en) * 2001-08-29 2003-03-13 Kyogo Itoh Desensitizers
EP1556082A1 (de) * 2002-10-22 2005-07-27 Aventis Pasteur Limited Impfstoffe gegen krebs mit hochdosierten zytokinen als adjuvans
RU2546540C2 (ru) * 2011-07-06 2015-04-10 Федеральное государственное бюджетное учреждение "Научно-исследовательский Институт гриппа" Министерства здравоохранения и социального развития Российской Федерации (ФГБУ "НИИ гриппа" Минздравсоцразвития России) Способ профилактики гриппа путем сочетанного применения интерферона гамма и инактивированной противогриппозной вакцины

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9818445D0 (en) * 1998-08-24 1998-10-21 Imp College Innovations Ltd Medicaments

Also Published As

Publication number Publication date
DE60026666T2 (de) 2006-11-09
CA2313392A1 (en) 2001-01-22
EP1074267B1 (de) 2006-03-15
EP1074267A1 (de) 2001-02-07
EP1681064A1 (de) 2006-07-19
DE60026666D1 (de) 2006-05-11

Similar Documents

Publication Publication Date Title
ITTO950367A0 (it) Proteine di prrsv ricombinanti, corredi diagnostici e vaccini contenenti tali proteine di prrsv ricombinanti.
FI951138A0 (fi) Puuttellisia adenovirusvektoreita ja niiden käyttö geeniterapiassa
NL192275B (nl) Eiwit van het AIDS-virus.
AU1593001A (en) Recombinant gelatin in vaccines
DE69931507D1 (de) Interferon-beta fusionsproteine und deren verwendungen
NO20016243D0 (no) Anti-alfav-beta3-rekombinante humane antistoffer, nukleinsyrer som koder for de samme og fremgangsmåter foranvendelse
ATE141946T1 (de) Hiv-2-virusvarianten
NO971875L (no) Cathepsin 02 protease
NO995182L (no) Pattedyrcytokinlignende faktor 7
PT698216E (pt) Metodos de tipificacao do virus da hepatite c e reagentes para utilizar nestes
DE69132545D1 (de) Protein mit Cytokinaktivität, Rekombinant-DNS, Expressionsvektor und Wirtszellen zu seiner Herstellung
NO910103L (no) Non-a, non-b genomisk hepatittvirus cdna samt tilsvarendepolypeptid-antigen.
WO2001025438A3 (en) Ifn-alpha homologues
EP1147212A4 (de) T-helferzellen-epitope
ATE320266T1 (de) Induktion von antigen-spezifischen t-zellen durch interferon
DE69331977D1 (de) Löslicher LDL-Rezeptor, seine Herstellung und Verwendung
FI970097L (fi) Proteiinit, jotka ovat peräisin nisäkkäiden maksasta ja niiden käyttö onkologiassa
ATE385805T1 (de) Neue peptide
OA09653A (en) Rubella peptides
NO950420L (no) Interferon endelse derav
NO894573L (no) Rekombinante interleukin-2 hybridproteiner.
ATE315646T1 (de) Leukocyten-aktivierender faktor
DE69328488D1 (de) Peptide, analoge und ihre mischungen zur detektion und erzeugung von antikörpern gegen die e1 und e2 proteine des rubella virus
IT1270941B (it) Peptidi di hcv e loro usi.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties